EGLN1

Chr 1AD

egl-9 family hypoxia inducible factor 1

Also known as: C1orf12, ECYT3, HALAH, HIF-PH2, HIFPH2, HPH-2, HPH2, PHD2

The protein encoded by this gene catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis. This protein functions as a cellular oxygen sensor, and under normal oxygen concentration, modification by prolyl hydroxylation is a key regulatory event that targets HIF subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex. Mutations in this gene are associated with erythrocytosis familial type 3 (ECYT3). [provided by RefSeq, Nov 2009]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.302 OMIM phenotypes
Clinical SummaryEGLN1
🧬
Gene-Disease Validity (ClinGen)
EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.97). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 707 VUS of 1319 total submissions
📖
GeneReview available — EGLN1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.30LOEUF
pLI 0.974
Z-score 3.43
OE 0.06 (0.020.30)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.15Z-score
OE missense 0.58 (0.500.67)
119 obs / 205.8 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.06 (0.020.30)
00.351.4
Missense OE?0.58 (0.500.67)
00.61.4
Synonymous OE?1.29
01.21.6
LoF obs/exp: 1 / 15.7Missense obs/exp: 119 / 205.8Syn Z: -2.09

This gene — mechanism propensity

DN
0.3296th %ile
GOF
0.4481th %ile
LOF
0.67top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 87% of P/LP variants are LoF · LOEUF 0.30
GOF1 literature citation

Literature Evidence

GOFA genetic mechanism for Tibetan high-altitude adaptation1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 25129147

ClinVar Variant Classifications

1319 submitted variants in ClinVar

Classification Summary

Pathogenic13
Likely Pathogenic2
VUS707
Likely Benign481
Benign60
Conflicting47
13
Pathogenic
2
Likely Pathogenic
707
VUS
481
Likely Benign
60
Benign
47
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
11
2
0
0
13
Likely Pathogenic
2
0
0
0
2
VUS
7
616
84
0
707
Likely Benign
0
28
38
415
481
Benign
0
1
58
1
60
Conflicting
47
Total206471804161,310

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

36 pathogenic / likely-pathogenic (of 41) ClinVar copy-number / structural variants overlap EGLN1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

EGLN1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →